These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12667386)

  • 21. [Efficacy and safety of arbidol in treatment of naturally acquired influenza].
    Wang MZ; Cai BQ; Li LY; Lin JT; Su N; Yu HX; Gao H; Zhao JZ; Liu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):289-93. PubMed ID: 15266832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.
    Dobson J; Whitley RJ; Pocock S; Monto AS
    Lancet; 2015 May; 385(9979):1729-1737. PubMed ID: 25640810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized double-blind controlled study of laninamivir compared with oseltamivir for the treatment of influenza in patients with chronic respiratory diseases.
    Watanabe A
    J Infect Chemother; 2013 Feb; 19(1):89-97. PubMed ID: 22907567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
    Hayden FG; Atmar RL; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills RG
    N Engl J Med; 1999 Oct; 341(18):1336-43. PubMed ID: 10536125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
    Hayden FG; Sugaya N; Hirotsu N; Lee N; de Jong MD; Hurt AC; Ishida T; Sekino H; Yamada K; Portsmouth S; Kawaguchi K; Shishido T; Arai M; Tsuchiya K; Uehara T; Watanabe A;
    N Engl J Med; 2018 Sep; 379(10):913-923. PubMed ID: 30184455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy and safety of oseltamivir in children with suspected influenza: a multicenter randomized open-label trial].
    He CH; Liu CY; Lin GY; Peng Q; Liao JY; Lin JH; Zhang T; Zheng XF; Lin CX; Wang SJ; Chen RS; Deng L; Chen YM
    Zhonghua Er Ke Za Zhi; 2017 Jun; 55(6):462-467. PubMed ID: 28592016
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.
    Duval X; van der Werf S; Blanchon T; Mosnier A; Bouscambert-Duchamp M; Tibi A; Enouf V; Charlois-Ou C; Vincent C; Andreoletti L; Tubach F; Lina B; Mentré F; Leport C;
    PLoS Med; 2010 Nov; 7(11):e1000362. PubMed ID: 21072246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial.
    Duan ZP; Jia ZH; Zhang J; Liu S; Chen Y; Liang LC; Zhang CQ; Zhang Z; Sun Y; Zhang SQ; Wang YY; Wu YL
    Chin Med J (Engl); 2011 Sep; 124(18):2925-33. PubMed ID: 22040504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
    Jefferson T; Jones M; Doshi P; Del Mar C
    BMJ; 2009 Dec; 339():b5106. PubMed ID: 19995812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
    Ison MG; Portsmouth S; Yoshida Y; Shishido T; Mitchener M; Tsuchiya K; Uehara T; Hayden FG
    Lancet Infect Dis; 2020 Oct; 20(10):1204-1214. PubMed ID: 32526195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
    N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children.
    Oo C; Barrett J; Hill G; Mann J; Dorr A; Dutkowski R; Ward P
    Paediatr Drugs; 2001; 3(3):229-36. PubMed ID: 11310719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral oseltamivir in human experimental influenza B infection.
    Hayden FG; Jennings L; Robson R; Schiff G; Jackson H; Rana B; McClelland G; Ipe D; Roberts N; Ward P
    Antivir Ther; 2000 Sep; 5(3):205-13. PubMed ID: 11075941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.
    Gillissen A; Höffken G
    Med Microbiol Immunol; 2002 Dec; 191(3-4):165-8. PubMed ID: 12458353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
    Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
    Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and safety of Kangbingdu granules in the treatment of influenza: a randomized, double-blind, double-dummy, positive-drug parallel control multicenter clinical trial].
    Nong Y; Lin JT; Sun XW; Wang J; Ma X; Liu XP; Wang HQ; Zha RT; Shen DP; Jiang SJ; Luo SK; Zhao Q; Meng L; Wang WP; Fang J; Han LM; Lu GB; Zhang W; Li GF; Wang H; Zhao ZY; Zhou W; Wei BL; Yuan YD; Peng LP; Lu XL; Pang GF; Li FH; Li L; Zhen H
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(3):205-211. PubMed ID: 33370867
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness of oseltamivir on influenza and influencing factors: age of patients, type of influenza virus and timing of initial administration].
    Kawai N; Iwaki N; Kawashima T; Satoh I; Tsuchimoto T; Shigematsu T; Kondoh K; Maeda T; Hirotsu N; Kunishima O; Kashiwagi S
    Kansenshogaku Zasshi; 2003 Jun; 77(6):423-9. PubMed ID: 12872691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama.
    Dawood FS; Jara J; Gonzalez R; Castillo JM; De León T; Estripeaut D; Luciani K; Sujey Brizuela Y; Barahona A; Cazares RA; Lawson AM; Rodriguez M; de Viana D; Franco D; Castillo M; Fry AM; Gubareva L; Tamura D; Hughes M; Gargiullo P; Clara W; Azziz-Baumgartner E; Widdowson MA
    Antiviral Res; 2016 Sep; 133():85-94. PubMed ID: 27451343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.